These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 29869112)
1. Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis. Kavanaugh A; Singh R; Karki C; Etzel CJ; Kremer JM; Greenberg JD; Griffith J Clin Rheumatol; 2018 Aug; 37(8):2275-2280. PubMed ID: 29869112 [TBL] [Abstract][Full Text] [Related]
2. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368 [TBL] [Abstract][Full Text] [Related]
3. Long-term remission and biologic persistence rates: 12-year real-world data. Murray K; Turk M; Alammari Y; Young F; Gallagher P; Saber T; Fearon U; Veale DJ Arthritis Res Ther; 2021 Jan; 23(1):25. PubMed ID: 33441191 [TBL] [Abstract][Full Text] [Related]
4. Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry. Harrold LR; Stolshek BS; Rebello S; Collier DH; Mutebi A; Wade SW; Malley W; Greenberg JD; Etzel CJ Clin Rheumatol; 2017 Apr; 36(4):895-901. PubMed ID: 28271234 [TBL] [Abstract][Full Text] [Related]
5. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings. Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. Reddy SM; Anandarajah AP; Fisher MC; Mease PJ; Greenberg JD; Kremer JM; Reed G; Chen R; Messing S; Kaukeinen K; Ritchlin CT J Rheumatol; 2010 Dec; 37(12):2566-72. PubMed ID: 20843908 [TBL] [Abstract][Full Text] [Related]
7. Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA. Iannone F; Favalli EG; Caporali R; D'Angelo S; Cantatore FP; Sarzi-Puttini P; Foti R; Conti F; Carletto A; Gremese E; Cauli A; Ramonda R; Palermo A; Epis O; Priora M; Bergossi F; Frediani B; Salaffi F; Lopalco G; Cacciapaglia F; Marchesoni A; Biggioggiero M; Bugatti S; Balduzzi S; Carriero A; Corrado A; Bongiovanni S; Benenati A; Miranda F; Fracassi E; Perra D; Ferraccioli G; Lapadula G Joint Bone Spine; 2021 Jan; 88(1):105062. PubMed ID: 32755721 [TBL] [Abstract][Full Text] [Related]
8. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M; J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755 [TBL] [Abstract][Full Text] [Related]
10. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D; Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440 [TBL] [Abstract][Full Text] [Related]
11. Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry. Kavanaugh A; Keystone E; Greenberg JD; Reed GW; Griffith JM; Friedman AW; Saunders KC; Ganguli A Rheumatology (Oxford); 2017 Jul; 56(7):1095-1101. PubMed ID: 28340006 [TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Michelsen B; Uhlig T; Sexton J; van der Heijde D; Hammer HB; Kristianslund EK; Wierød A; Bakland G; Rødevand E; Krøll F; Loge JH; Haugeberg G; Kvien TK Ann Rheum Dis; 2018 Sep; 77(9):1290-1294. PubMed ID: 29875096 [TBL] [Abstract][Full Text] [Related]
13. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. Sokoll KB; Helliwell PS J Rheumatol; 2001 Aug; 28(8):1842-6. PubMed ID: 11508587 [TBL] [Abstract][Full Text] [Related]
14. Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries. Mease PJ; Liu M; Rebello S; Kang H; Yi E; Park Y; Greenberg JD Rheumatol Ther; 2019 Dec; 6(4):529-542. PubMed ID: 31529278 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study. Alvarez-Madrazo S; Kavanagh K; Siebert S; Semple Y; Godman B; Maciel Almeida A; Acurcio FA; Bennie M BMJ Open; 2019 Sep; 9(9):e027059. PubMed ID: 31488467 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort. Gross RL; Schwartzman-Morris JS; Krathen M; Reed G; Chang H; Saunders KC; Fisher MC; Greenberg JD; Putterman C; Mease PJ; Gottlieb AB; Kremer JM; Broder A Arthritis Rheumatol; 2014 Jun; 66(6):1472-81. PubMed ID: 24591475 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of psoriatic arthritis switch quality assessment tool (PASQAL) - an outcomes measurement tool to assess the quality of biologic switch decisions in psoriatic arthritis. Laires PA; Carrilho M; Tavares-Costa J; Lucas P; Machado P; Cunha-Miranda L; Pimentel-Santos F; Santos H; Vieira-Sousa E; Santos MJ Acta Reumatol Port; 2020; 45(1):46-57. PubMed ID: 32578579 [TBL] [Abstract][Full Text] [Related]
18. Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study. Giacomelli R; Gorla R; Trotta F; Tirri R; Grassi W; Bazzichi L; Galeazzi M; Matucci-Cerinic M; Scarpa R; Cantini F; Gerli R; Lapadula G; Sinigaglia L; Ferraccioli G; Olivieri I; Ruscitti P; Sarzi-Puttini P Rheumatology (Oxford); 2015 May; 54(5):792-7. PubMed ID: 25288786 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239 [TBL] [Abstract][Full Text] [Related]
20. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis. Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT; J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]